- Home
- CUBI vs AMPH Comparison
CUBI vs AMPH Comparison
Compare CUBI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBI
- AMPH
- Stock Information
- Founded
- CUBI 1994
- AMPH 1996
- Country
- CUBI United States
- AMPH United States
- Employees
- CUBI N/A
- AMPH N/A
- Industry
- CUBI Major Banks
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- CUBI Finance
- AMPH Health Care
- Exchange
- CUBI Nasdaq
- AMPH Nasdaq
- Market Cap
- CUBI 1.4B
- AMPH 2.5B
- IPO Year
- CUBI 2012
- AMPH 2014
- Fundamental
- Price
- CUBI $46.46
- AMPH $51.45
- Analyst Decision
- CUBI Buy
- AMPH Buy
- Analyst Count
- CUBI 8
- AMPH 4
- Target Price
- CUBI $63.86
- AMPH $63.00
- AVG Volume (30 Days)
- CUBI 290.2K
- AMPH 268.7K
- Earning Date
- CUBI 10-31-2024
- AMPH 11-06-2024
- Dividend Yield
- CUBI N/A
- AMPH N/A
- EPS Growth
- CUBI 33.08
- AMPH 62.07
- EPS
- CUBI 7.41
- AMPH 3.15
- Revenue
- CUBI $722,462,000.00
- AMPH $712,891,000.00
- Revenue This Year
- CUBI N/A
- AMPH $18.04
- Revenue Next Year
- CUBI $11.71
- AMPH $4.41
- P/E Ratio
- CUBI $6.12
- AMPH $16.26
- Revenue Growth
- CUBI 25.87
- AMPH 31.80
- 52 Week Low
- CUBI $38.69
- AMPH $36.56
- 52 Week High
- CUBI $68.49
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- CUBI 48.18
- AMPH 59.40
- Support Level
- CUBI $44.31
- AMPH $49.38
- Resistance Level
- CUBI $47.11
- AMPH $51.84
- Average True Range (ATR)
- CUBI 1.57
- AMPH 1.25
- MACD
- CUBI 0.05
- AMPH 0.10
- Stochastic Oscillator
- CUBI 28.96
- AMPH 78.90
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.